Hamza Suria's Insider Trades & SAST Disclosures
Hamza Suria's most recent trade in AnaptysBio Inc was a trade of 200,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 10, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Hamza Suria.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 36,645 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 20 Dec 2021 | 36,645 | 105,245 (0%) | 0% | 1.1 | 41,042 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 35.75 per share. | 20 Dec 2021 | 19,208 | 74,122 (0%) | 0% | 35.8 | 686,776 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 34.89 per share. | 20 Dec 2021 | 11,915 | 93,330 (0%) | 0% | 34.9 | 415,756 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 36.40 per share. | 20 Dec 2021 | 5,522 | 68,600 (0%) | 0% | 36.4 | 201,026 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 22.03 per share. | 15 Nov 2021 | 964 | 68,600 (0%) | 0% | 22.0 | 21,237 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 14,302 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 04 Nov 2021 | 14,302 | 67,636 (0%) | 0% | 35 | 500,570 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 04 Nov 2021 | 14,302 | 81,938 (0%) | 0% | 1.1 | 16,018 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 04 Nov 2021 | 6,059 | 67,636 (0%) | 0% | 35 | 212,065 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 04 Nov 2021 | 6,059 | 73,695 (0%) | 0% | 1.1 | 6,786 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 6,059 | 14,302 | - | - | Employee Stock Option (Right to Buy) | |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 01 Nov 2021 | 36,646 | 104,282 (0%) | 0% | 1.1 | 41,044 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 36,646 | 36,645 | - | - | Employee Stock Option (right to buy) | |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 32.27 per share. | 01 Nov 2021 | 34,087 | 70,195 (0%) | 0% | 32.3 | 1,099,967 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 32.88 per share. | 01 Nov 2021 | 2,559 | 67,636 (0%) | 0% | 32.9 | 84,139 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Oct 2021 | 15,993 | 73,291 | - | - | Employee Stock Option (right to buy) | |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 26 Oct 2021 | 15,993 | 67,636 (0%) | 0% | 30 | 479,790 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 26 Oct 2021 | 15,993 | 83,629 (0%) | 0% | 1.1 | 17,912 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 17 Sep 2021 | 10,000 | 67,636 (0%) | 0% | 1.1 | 11,200 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2021 | 10,000 | 20,361 | - | - | Employee Stock Option (right to buy) | |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 12 May 2021 | 10,000 | 57,636 (0%) | 0% | 1.1 | 11,200 | Common Stock |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2021 | 10,000 | 30,361 | - | - | Employee Stock Option (right to buy) | |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 119,700 | 119,700 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges